Bio-Rad Laboratories (BIO) Capital Expenditures (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Capital Expenditures for 18 consecutive years, with $32.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Capital Expenditures fell 29.98% year-over-year to $32.0 million in Q2 2026; TTM through Jun 2026 was $139.5 million, a 14.52% decrease from a year earlier, with the FY2025 full-year figure at $157.6 million, down 4.83% from the prior year.
• Capital Expenditures was $32.0 million for Q2 2026 at Bio-Rad Laboratories, up from $30.0 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $45.8 million in Q4 2025 and troughed at $17.3 million in Q2 2022.
• A 5-year average of $36.4 million and a median of $35.3 million in 2022 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures sank 38.04% in 2022 and soared 99.83% in 2023, its largest moves.
• Over 5 years, Capital Expenditures stood at $34.8 million in 2022, then gained by 21.41% to $42.3 million in 2023, then climbed by 1.5% to $42.9 million in 2024, then rose by 6.76% to $45.8 million in 2025, then plunged by 30.13% to $32.0 million in 2026.
• The last three Capital Expenditures figures came in at $32.0 million (Q2 2026), $30.0 million (Q1 2026), and $45.8 million (Q4 2025), per Business Quant data.